businesspress24.com - Nutter's Life Sciences Group Hosts Executive Forum on May 2nd
 

Nutter's Life Sciences Group Hosts Executive Forum on May 2nd

ID: 1107174

The Business of Invention: Patenting for Biotechs

(firmenpresse) - BOSTON, MA -- (Marketwire) -- 04/25/12 -- The Life Sciences Group of the law firm of Nutter McClennen & Fish LLP will present on Wednesday, May 2nd from 7:30 - 9:30 a.m., a forum for biotech executives and general counsel, BD, CSOs and biomedical inventors involved in the creation and commercialization of IP. The forum will be held at Nutter's office at 155 Seaport Boulevard in Boston.

For a full description of this event, and to register, please go to: or call 617-439-2985.

Konstantin Linnik, Ph.D., a partner in the firm's IP and Life Sciences practice groups and a former senior counsel at Pfizer, will present on the following topics:

What to patent and what to keep as a trade secret

How to properly maintain lab notebooks

How to address competitors' IP and freedom to operate

Implications of the new US patent reform

Nutter McClennen & Fish LLP has a long track record working with life sciences companies throughout the product lifecycle to achieve their legal and business objectives. The firm represents an international roster of innovative clients involved in a range of sophisticated technologies in the biotechnology, medical device, and pharmaceutical industries, as well as renowned medical institutions and research universities, emerging growth companies and angel and venture capital firms. Nutter's expertise spans IP strategy, prosecution and litigation; strategic collaborations and licensing; clinical trials and regulatory compliance; as well as M&A, capital raising and finance, government investigations and defense, and product liability.



Lisa Jentzen
617-439-2894




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  ProMetic Receives $1.9 Million Follow-On Order From a US Based Biopharmaceutical Company
Cytokinetics Announces Encouraging Results From Two Phase II Clinical Trials Evaluating CK-2017357 in Patients With Amyotrophic Lateral Sclerosis
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 25.04.2012 - 11:30 Uhr
Sprache: Deutsch
News-ID 1107174
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

BOSTON, MA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 131 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Nutter's Life Sciences Group Hosts Executive Forum on May 2nd
"
steht unter der journalistisch-redaktionellen Verantwortung von

Nutter McClennen & Fish (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Nutter McClennen & Fish



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 84


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.